Categories
Connect with us on LinkedIn
Castor Inks Big Pharma Deal As Decentralized Trials Business Continues to Show Exponential Growth
Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing...
A Guide to Capturing and Managing Data in Digital Therapeutics Trials
This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote...
Why Remote Consent Is the New Normal in 2021
COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do...
Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth
Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch...
Top 4 eConsent Questions from Clinical Researchers
In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges...
Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform
Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s...
eBook: The Decentralized Clinical Trial Playbook
This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote...
Decentralized Trial Tech Strategy In Three Steps
Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has...
Research Continuity During COVID-19
Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with...
Common shortcomings of clinical research data for PMCF
The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here...
Castor is now live in Australia!
To support our growing customer base in the APAC region, we established new hosting in Australia. By allowing...
eConsent – The Enrollment Solution for Decentralized Trials
Join this webinar to understand how eConsent works, where it falls in the regulatory guidelines & see a...
Castor Announces Partnership With Click Therapeutics to Support Decentralized Clinical Trials
Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research...
Castor Raises a $12M Series A to Further Their Support for COVID-19 Research
With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further...
An Expert Panel on Decentralized and Hybrid Trials, Pre and Post COVID-19
The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than...
What Will Trial Enrollment & Engagement Look Like in a Socially-Distanced World?
When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to...
Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond
Download this white paper to learn why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are...
Protocol Deviations in Clinical Trials: Understanding the FDA’s Guidance
Protocol deviations can seriously impact the integrity of clinical trials, and with regulatory scrutiny growing, it’s crucial to...
Connect with us on LinkedIn
